Samaritan North Lincoln Hospital
Samaritan North Lincoln Hospital was paid $12.27M by Medicaid between Jan 2018 and Nov 2024, across 62 billing codes. Its largest line is 99283, emergency room visit (moderate) — 39% of everything it billed.
LINCOLN CITY, OR 97367
Next to other Critical Access Hospital providers in Oregon
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,906 | $1.30M | |
| 2019 | 17,866 | $1.33M | |
| 2020 | 16,353 | $1.24M | |
| 2021 | 22,764 | $1.80M | |
| 2022 | 24,325 | $1.94M | |
| 2023 | 23,116 | $2.25M | |
| 2024incomplete | 20,811 | $2.41M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 39% | 25,020 | 16,504 | $4.73M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 36% | 15,427 | 9,885 | $4.41M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.8% | 9,904 | 7,178 | $831K |
| 80053 | Comprehensive metabolic panel | 3.1% | 15,339 | 12,797 | $383K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.8% | 16,164 | 13,311 | $339K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.0% | 712 | 509 | $245K |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 24,040 | 20,140 | $195K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 2,697 | 2,267 | $176K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 1,639 | 1,452 | $132K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,249 | 2,849 | $122K |
| 81514 | <1% | 294 | 253 | $85K | |
| 81001 | <1% | 5,153 | 4,489 | $78K |
50 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 942 | $65K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 735 | $45K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,393 | $40K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,248 | $37K |
| 84484 | <1% | 1,163 | $36K | |
| 71045 | Radiologic examination, chest; single view | <1% | 431 | $29K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 3,262 | $28K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 412 | $24K |
| 80061 | Lipid panel | <1% | 1,035 | $24K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 3,534 | $18K |
| 85610 | <1% | 1,343 | $18K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 940 | $17K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 843 | $16K |
| 83690 | <1% | 655 | $15K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 262 | $15K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 262 | $15K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 346 | $13K |
| 83605 | <1% | 618 | $13K | |
| 83735 | <1% | 802 | $12K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 346 | $7K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 40 | $6K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 12 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 27 | $4K |
| 88142 | <1% | 87 | $4K | |
| 80306 | <1% | 57 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 132 | $3K |
| 83880 | <1% | 49 | $3K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 31 | $3K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 87 | $3K |
| 85730 | <1% | 146 | $2K | |
| 85027 | <1% | 204 | $2K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 18 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 80 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 70 | $2K |
| 96367 | <1% | 46 | $2K | |
| J3490 | Unclassified drugs | <1% | 77 | $1K |
| A9270 | Non-covered item or service | <1% | 1,414 | $1K |
| 87800 | <1% | 45 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 13 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 53 | $1K |
| 82607 | <1% | 33 | $988.67 | |
| 0001A | <1% | 36 | $919.20 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 14 | $882.00 |
| 82803 | <1% | 21 | $826.14 | |
| 82746 | <1% | 12 | $705.60 | |
| 0011A | <1% | 22 | $638.40 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 17 | $577.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 30 | $540.96 |
| 91300 | 0% | 36 | $0.00 | |
| 91301 | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Samaritan Pacific Health Services, INC | Newport, OR | $20.55M |
| Samaritan Pacific Health Services, INC. | Corvallis, OR | $7.21M |
| Samaritan Pacific Health Services INC | Newport, OR | $2.69M |
| Samaritan North Lincoln Hospital | Lincoln City, OR | $1.79M |
| Samaritan North Lincoln Hospital | Lincoln City, OR | $1.34M |
| Samaritan Pacific Health Services, INC. | Newport, OR | $1.18M |
| Samaritan Pacific Health Services, INC. | Waldport, OR | $1.12M |
| Samaritan Pacific Health Services, INC. | Toledo, OR | $1.02M |
| Samaritan Pacific Health Services INC | Depoe Bay, OR | $472K |
| Samaritan Pacific Health Services INC | Newport, OR | $157K |
| Samaritan North Lincoln Hospital | Lincoln City, OR | $21K |
| Samaritan Pacific Health Services INC | Newport, OR | $17K |
| Samaritan Pacific Health Services | Newport, OR | $11K |
| Samaritan Pacific Health Services INC | Newport, OR | $11K |
| Samaritan North Lincoln Hospital | Lincoln City, OR | $8K |
| Samaritan Pacific Health Services, INC | Depoe Bay, OR | $3K |
| Samaritan Pacific Health Services INC | Newport, OR | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.